MAI CDMO

MAI CDMO is a leading Contract Development and Manufacturing Organization (CDMO) specializing in the development and production of biologics and advanced pharmaceutical products. With state-of-the-art facilities and a highly experienced team, MAI CDMO offers comprehensive services from early-stage development to full-scale commercial manufacturing. The company supports global biotech and pharmaceutical partners with solutions tailored for monoclonal antibodies, recombinant proteins, and cell-based therapies. Committed to quality, innovation, and regulatory excellence, MAI CDMO ensures seamless project execution while accelerating product timelines. Their customer-centric approach and proven track record make them a trusted partner in the life sciences industry.